Search for: "Novartis Pharma AG"
Results 21 - 40
of 124
Sort by Relevance
|
Sort by Date
18 Oct 2018, 2:30 pm
First, the application to bring back Zelnorm was made by Sloan Pharma, which acquired the rights to Zelnorm from Novartis. [read post]
29 Jun 2018, 11:13 am
In its ruling, the Court ordered Teva to pay Novartis more than €13,000,000 as an advance on damages (€5,846,628 to Novartis Pharma AG, the Swiss company which owns the patent, and €7,308,285 to Novartis Pharma SAS, the French licensee). [read post]
25 Jun 2018, 3:49 am
Starting from 2009, when the Supreme Commercial Court restrained a generic drug for the first time (Novartis AG vs. [read post]
1 Dec 2017, 11:35 am
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
28 Nov 2017, 7:25 am
Dramatically Higher Price The newly approved drug, KymriahTM (tisagenlecleucel), manufactured by Novartis, brings hope to the 3,100 people under the age of 20 in the United States who are diagnosed each year with acute lymphoblastic leukemia. [read post]
15 May 2017, 2:32 am
Novartis AG. [read post]
21 Apr 2017, 6:15 am
The Federal Circuit affirmed a Patent Trial and Appeal Board (“Board”) decision finding a patent owned by Novartis AG and Mitsubishi Tanabe Pharma Corp. [read post]
12 Apr 2017, 9:52 am
Patent No.8,324,283 (the ’283 patent), owned by Novartis AG andMistubishi Tanabe Pharma Corp. [read post]
22 Sep 2016, 5:32 pm
An ageing population and the increase in chronic diseases are driving a dramatic market expansion. [read post]
16 Sep 2016, 4:07 am
A related issue was whether Novartis Pharma AG (Novartis) was the exclusive licensee of Orion’s 765932 patent and had the right to sue for infringement in these proceedings. [read post]
29 Jan 2016, 3:58 am
If you want a reason to hate Novartis, look to Obamacare’s failure to address big pharma costs to buy its love and support for passage. [read post]
4 Dec 2015, 2:55 am
Novartis AG & Novartis GmbH regarding the validity and (in)direct infringement of EP 0296 689, Novartis’ Swiss type 2nd medical use patent covering the use of zoledronate in the preparation of a medicament for the treatment of osteoporosis. [read post]
3 May 2015, 10:33 pm
With this note, he provides further food for thought on patent law’s complexity, from Bilski to Teva v Leo Pharma, to the relation between patent law and economics. [read post]
2 Mar 2015, 2:43 pm
Never too late 33 [week ending Sunday 15 February] –- Evoking Audrey Hepburn’s image is not OK in Italy | Reasonable royalty and moral prejudice: new reference to the CJEU | CoA for England and Wales on parallel importations in Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH | The Logic of Innovation: Intellectual Property, and What the User Found There and Tritton on Intellectual Property in Europe reviewed | Italian baked goods’… [read post]
23 Feb 2015, 2:55 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
22 Feb 2015, 9:59 pm
Pfizer, Inc. 2:15-cv-01283; filed February 18, 2015 in the District Court of New Jersey • Plaintiffs: Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG • Defendant: Pfizer, Inc. [read post]
16 Feb 2015, 1:44 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
15 Feb 2015, 9:43 pm
Novartis AG et al. v. [read post]
9 Feb 2015, 1:15 am
| Dutch diverge with English as Novartis prevails on Zoledronic Acid in Netherlands | Slogan and TMs | The coffee capsule wars | Declining public trust in innovation | IPEC’s ruling in Global Flood Defence Systems & Another v Van den Noort Innovations BV & Others | Again on CJEU ruling in Case C-419/13 Art & Allposters | Biotech financing: the risk components, ‘going long’ and patents as knowledge currency. [read post]
8 Feb 2015, 9:59 pm
Roxane Laboratories Inc. 1:15-cv-00128; filed February 5, 2015 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
